Anika Therapeutics Release: Hyalomatrix Receives CMS Reimbursement Coverage In 11 States

BEDFORD, Mass.--(BUSINESS WIRE)--Hyalomatrix, a unique advanced wound care device based on hyaluronic acid (HA) technology, is now eligible for reimbursement as a skin substitute through the Centers for Medicare and Medicaid Services (CMS) in 11 states and D.C. after receiving positive local coverage determination (LCD) changes in Arkansas, Colorado, Delaware, Louisiana, Maryland, Mississippi, New Jersey, New Mexico, Oklahoma, Pennsylvania, Texas, and Washington D.C.

Help employers find you! Check out all the jobs and post your resume.